Safety and Tolerability of Antipsychotics
- 8 December 2015
- book chapter
- Published by Springer Nature
- p. 167-189
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System DatabaseDrug Safety, 2013
- Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series reportBMC Psychiatry, 2012
- Prediabetes in Patients Treated With Antipsychotic DrugsThe Journal of Clinical Psychiatry, 2011
- Analysis of Adverse Drug Reactions of Atypical Antipsychotic Drugs in Psychiatry OPDIndian Journal of Psychological Medicine, 2011
- Sudden Deaths in Psychiatric PatientsThe Journal of Clinical Psychiatry, 2011
- Incidence of Tardive Dyskinesia with Risperidone or Olanzapine in the Elderly: Results from a 2-Year, Prospective Study in Antipsychotic-Naïve PatientsNeuropsychopharmacology, 2011
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of casesBMC Psychiatry, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With SchizophreniaSchizophrenia Bulletin, 2007
- ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with DementiaNeuropsychopharmacology, 2007